کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3319589 | 1211701 | 2008 | 8 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Predictive Markers in Colorectal Cancer
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
بیماریهای گوارشی
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Predictive Markers in Colorectal Cancer Predictive Markers in Colorectal Cancer](/preview/png/3319589.png)
چکیده انگلیسی
In 2008, the optimal treatment for colorectal cancer remains unsettled. In the metastatic setting, several drugs are approved and commonly used; 5-fluorouracil, irinotecan, oxaliplatin, bevacizumab, cetuximab and panitumumab. Improvements in survival have been observed with combination of these agents although questions persist-which combination of agents is the best drug regimen, when is the most appropriate time for their use, and which regimen is the most cost-effective and manageable in terms of toxicities? The resolution of these issues requires the identification of markers capable of predicting which patients are most likely to benefit and avoid untoward side effects. Advances in the predictive marker field have recently been made especially in regards to K-RAS status in the use of EGFR monoclonal antibodies. Work on other potential predictors is ongoing. This review examines the current knowledge of predictive markers for drugs approved for colorectal cancer.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Seminars in Colon and Rectal Surgery - Volume 19, Issue 4, December 2008, Pages 231-238
Journal: Seminars in Colon and Rectal Surgery - Volume 19, Issue 4, December 2008, Pages 231-238
نویسندگان
George P. MD,